Oxidative stress and inflammation in the endothelial dysfunction of obesity: A role for nuclear factor kappa B?

Journal of Hypertension

Volumn 28, Issue 10, 2010, Pages 2010-2011

  Quilley, John ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SALICYLATE SODIUM; SUPEROXIDE DISMUTASE;

DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; INFLAMMATION; NONHUMAN; NOTE; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; VASODILATATION;

EID: 77957258849     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833e24cb     Document Type: Note

References (15)

1. Kobayasi R, Akamine EH, Davel AP, Rodrigues MA, Carvalho CR, Venturini Rossoni L. Oxidative stress and inflammatory mediators contribute to endothelial dysfunction in high-fat diet-induced obesity in mice. J Hypertens 2010; 28:2111-2119.
2. Maxwell S, Greig L. Antioxidants: a protective role in cardiovascular disease? Expert Opin Pharamcother 2001; 2:1737-1750.
3. Knight SF, Yuan J, Roy S, Imig JD. Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension. Am J Physiol Renal Physiol 2010; 298:F86-F94.
4. Elmarakby AA, Quigley JE, Imig JD, Pollock JS, Pollock DM. TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2008; 294:R76-R83.
5. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989; 3:2007-2018.
6. Traupe T, Lang M, Goettsch W, Munter K, Morawietz H, Vetter W, Barton M. Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression. J Hypertens 2002; 20:22392245.
7. Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V, et al. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 2003; 107:1017-1023.
8. Shi Y, Vanhoutte PM. Oxidative stress and COX cause hyper-responsiveness in vascular smooth muscle of the femoral artery from diabetic rats. Br J Pharmacol 2008; 154:639-651.
9. Wu KK. Aspirin and other cyclooxygenase inhibitors: new therapeutic insights. Semin Vasc Med 2003; 3:107-112.
10. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996; 97:2601-2610.
11. Ding H, Triggle CR. Endothelial dysfunction in diabetes: multiple targets for treatment. Pflugers Arch 2010; 459:977-994.
12. Ketonen J, Pilvi T, Mervaala E. Caloric restriction reverses high-fat diet-induced endothelial dysfunction and vascular superoxide production in C57B1/6 mice. Heart Vessels 2010; 25:254-262.
13. Ketonen J, Shi J, Martonen E, Mervaala E. Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57B1/6 mice. Circ J 2010; 74:1479-1487.
14. Elmarakby AA, Imig JD. Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats. Clin Sci 2010; 118:291-301.
15. Pierce GL, Lesniewski LA, Lawson BR, Beske SD, Seals DR. NFkB activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans. Circulation 2009; 119:1284-1292.